Authors: Martha Powell, Future Science Group
Researchers have studied macaque models of antiretroviral-treated HIV, discovering that persistent inflammation may underlie neurocognitive impairments in humans.
Combination antiretroviral therapy (cART) has improved the survival of many HIV-infected patients and has also reduced the incidence of neurological complications. However, almost half of cART-treated patients still experience some degree of neurological impairment.
To view restricted content, please:
